March 14, 2019
Weil is advising Brookfield Asset Management Inc. in its agreement to acquire a 62% stake of Oaktree Capital Management. The two companies together will have approximately $475 billion of assets under management and $2.5 billion of annual fee-related revenues, making this one of the leading alternative asset managers, with one of the most comprehensive suites of alternative investment products for investors worldwide. The transaction is expected to close in the third quarter of 2019 and is subject to the approval of Oaktree unitholders representing at least a majority of the voting interests of Oaktree and other customary closing conditions, including certain regulatory approvals.
The Weil team advising Brookfield is led by Mergers & Acquisitions partner Michael Aiello and includes Mergers & Acquisitions partners Matthew Gilroy and Eoghan Keenan and Mergers & Acquisitions associates Amanda Fenster, Brianna Dollinger and Shane Safer. The team also includes Private Equity partner Harvey Eisenberg; Head of U.S. Private Funds Jonathon Soler and Private Funds partner Cassie Kimmelman; Private Funds Regulatory partner David Wohl; Head of U.S. Banking & Finance Douglas Urquhart; Capital Markets partner Michael Hickey; Structured Finance & Derivatives partners Robert Chiperfield and Shawn Kodes; Technology & IP Transactions partner Karen Ballack; Co-Chair of Tax Joe Pari and Tax partners Chayim Neubort and Stanley Ramsay; Tax Co-Chair and Head of Executive Compensation & Benefits Paul Wessel; Private Equity Executive Compensation & Benefits Head Michael Nissan; International Arbitration & Trade partner Ted Posner; Antitrust/Competition partner Jeff White; White Collar Defense, Regulatory and Investigations partner Holly Loiseau; Complex Commercial Litigation partner Randi Singer; Environmental counsel John O’Loughlin; Private Equity associate Daniel Cohen; Private Funds associates Marc Schubert and Kimberly Snyder; Banking & Finance associate Jack Schinasi; Capital Markets associate Claire Logan; Structured Finance & Derivatives associates James Crook, Matthew Nemeth, Laura Edwards and Joel Hutman (Not Yet Admitted in New York); Technology & IP Transactions associate Alexa Chu Clinton;Tax associates Eric Remijan and Jake Meninga (Not Yet Admitted in New York); Executive Compensation & Benefits associates Craig Olshan and Travis Bruno (Not Yet Admitted in New York); Antitrust/Competition associate Megan Granger; and Complex Commercial Litigation associate Olivia Greer.